Quest Diagnostics Incorporated · NYSE:DGX
Delaney Mark E reported 1 trade in Quest Diagnostics Incorporated shares (Form 4)
Traded Apr 20, 2026 · Filed Apr 24, 2026
On Apr 20, 2026, Delaney Mark E (SVP & Chief Commercial Officer) reported 1 trade in Quest Diagnostics Incorporated shares at US$194.70 for US$7,204, leaving 11,901 shares. Filed Apr 24, 2026 (Form 4).
- Shares
- 37 shares
- Price
- US$194.70
- Value
- US$7,204
- Holding after
- 11,901 shares
- Trading plan
- No
- Role
- SVP & Chief Commercial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 20, 2026 | Common Stock | Other | 37 | US$194.70 | 11,901 | Direct |
Source
Related
- Quest Diagnostics Incorporated
- Delaney Mark E
- Quest Diagnostics Incorporated shareholders
- Form 4 · Delaney Mark E · Jul 29, 2026
- Form 4 · Delaney Mark E · Jul 27, 2026
- Form 4 · Davis J. E. · Sep 3, 2026
- Form 4 · Prevoznik Michael E · Aug 31, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Aug 14, 2026
- Form 4 · Kuppusamy Karthik · Jul 27, 2026
- Form 4 · Carter Robert B · Jul 27, 2026